{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:07:54Z","timestamp":1787504874129,"version":"build-2736575974"},"reference-count":38,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,12,1]]},"abstract":"<jats:p>Objective. We sought to determine the effect of coincident infection, at time of diagnosis of Kawasaki disease (KD), on treatment response and coronary artery outcome.<\/jats:p>\n                  <jats:p>Methods. A single-center, retrospective study of 129 consecutive patients diagnosed with typical KD between January 1997 and December 1998 was performed. Standardized clinical assessments, laboratory, microbiology, and imaging test results plus treatment regimens were reviewed. Coronary arteries were visualized by using echocardiography, and coronary artery lesions (CALs) were reported as body surface area\u2013adjusted z scores. Infection-positive and -negative groups were identified, and clinical, laboratory, and treatment data were analyzed. The effect of infections and other outcome variables on CAL development was determined by multivariate regression analysis.<\/jats:p>\n                  <jats:p>Results. (1) Concurrent infections: 33% of children with typical KD had \u22651 confirmed infection at KD diagnosis. (2) Treatment response: the presence of infection did not alter the response to treatment with intravenous immunoglobulin, with resolution of fever in 83% of children after 1 dose of intravenous immunoglobulin together with aspirin administration regardless of presence or absence of infection. (3) Coronary outcome: in total, 31% of the patients developed CALs. Both the proven-infection and no-proven-infection groups had a similar CAL frequency. (4) Multivariate regression analysis: proven infection did not increase the risk of coronary artery involvement even after adjusting for other factors impacting on coronary artery outcomes.<\/jats:p>\n                  <jats:p>Conclusions. Infections are common at diagnosis of KD. A broad spectrum of infectious agents was found. Infections at diagnosis of KD did not affect the patients' response to treatment and coronary artery outcome when compared with those patients without infections.<\/jats:p>","DOI":"10.1542\/peds.2005-0559","type":"journal-article","created":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T15:44:17Z","timestamp":1133451857000},"page":"e760-e766","source":"Crossref","is-referenced-by-count":133,"title":["Infections and Kawasaki Disease: Implications for Coronary Artery Outcome"],"prefix":"10.1542","volume":"116","author":[{"given":"Susanne M.","family":"Benseler","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Divisions of"},{"name":"Rheumatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian W.","family":"McCrindle","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Divisions of"},{"name":"Rheumatology"},{"name":"Cardiology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Earl D.","family":"Silverman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Divisions of"},{"name":"Rheumatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal N.","family":"Tyrrell","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Divisions of"},{"name":"Rheumatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Divisions of"},{"name":"Rheumatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rae S.M.","family":"Yeung","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Divisions of"},{"name":"Rheumatology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2005,12,1]]},"reference":[{"key":"2021121003230933800_R1","unstructured":"Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children [in Japanese]. Arerugi.\u20081967;16:178\u2013222"},{"key":"2021121003230933800_R2","doi-asserted-by":"crossref","unstructured":"Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association [published correction appears in Pediatrics. 2005;115:1118]. Pediatrics.\u20082004;114:1708\u20131733","DOI":"10.1542\/peds.2004-2182"},{"key":"2021121003230933800_R3","doi-asserted-by":"crossref","unstructured":"Yanagawa H, Nakamura Y, Ojima T, Yashiro M, Tanihara S, Oki I. Changes in epidemic patterns of Kawasaki disease in Japan. Pediatr Infect Dis J.\u20081999;18:64\u201366","DOI":"10.1097\/00006454-199901000-00015"},{"key":"2021121003230933800_R4","doi-asserted-by":"crossref","unstructured":"Nigro G, Zerbini M, Krzysztofiak A, et al. Active or recent parvovirus B19 infection in children with Kawasaki disease. Lancet.\u20081994;343:1260\u20131261","DOI":"10.1016\/S0140-6736(94)92154-7"},{"key":"2021121003230933800_R5","unstructured":"Barash J, Dushnitzky D, Sthoeger D, Bardenstein R, Barak Y. Human parvovirus B19 infection in children: uncommon clinical presentations. Isr Med Assoc J.\u20082002;4:763\u2013765"},{"key":"2021121003230933800_R6","doi-asserted-by":"crossref","unstructured":"Strigl S, Kutlin A, Roblin PM, Shulman S, Hammerschlag MR. Is there an association between Kawasaki disease and Chlamydia pneumoniae?J Infect Dis.\u20082000;181:2103\u20132105","DOI":"10.1086\/315526"},{"key":"2021121003230933800_R7","doi-asserted-by":"crossref","unstructured":"Anderson DG, Warner G, Barlow E. Kawasaki disease associated with streptococcal infection within a family. J Paediatr Child Health.\u20081995;31:355\u2013357","DOI":"10.1111\/j.1440-1754.1995.tb00827.x"},{"key":"2021121003230933800_R8","doi-asserted-by":"crossref","unstructured":"Ramanan AV, Baildam EM. Kawasaki disease following meningococcal septicaemia. Arch Dis Child.\u20082002;87:170\u2013171","DOI":"10.1136\/adc.87.2.170-b"},{"key":"2021121003230933800_R9","doi-asserted-by":"crossref","unstructured":"Burnell RH. Kawasaki disease with streptococcal infection. J Paediatr Child Health.\u20081996;32:270","DOI":"10.1111\/j.1440-1754.1996.tb01571.x"},{"key":"2021121003230933800_R10","doi-asserted-by":"crossref","unstructured":"Barton M, Melbourne R, Morais P, Christie C. Kawasaki syndrome associated with group A streptococcal and Epstein-Barr virus co-infections. Ann Trop Paediatr.\u20082002;22:257\u2013260","DOI":"10.1179\/027249302125001543"},{"key":"2021121003230933800_R11","doi-asserted-by":"crossref","unstructured":"Hall M, Hoyt L, Ferrieri P, Schlievert PM, Jenson HB. Kawasaki syndrome-like illness associated with infection caused by enterotoxin B-secreting Staphylococcus aureus. Clin Infect Dis.\u20081999;29:586\u2013589","DOI":"10.1086\/598638"},{"key":"2021121003230933800_R12","doi-asserted-by":"crossref","unstructured":"Meade RH 3rd, Brandt L. Manifestations of Kawasaki disease in New England outbreak of 1980. J Pediatr.\u20081982;100:558\u2013562","DOI":"10.1016\/S0022-3476(82)80752-X"},{"key":"2021121003230933800_R13","doi-asserted-by":"crossref","unstructured":"Wang JN, Wang SM, Liu CC, Wu JM. Mycoplasma pneumoniae infection associated with Kawasaki disease. Acta Paediatr.\u20082001;90:594\u2013595","DOI":"10.1111\/j.1651-2227.2001.tb00810.x"},{"key":"2021121003230933800_R14","doi-asserted-by":"crossref","unstructured":"Konishi N, Baba K, Abe J, et al. A case of Kawasaki disease with coronary artery aneurysms documenting Yersinia pseudotuberculosis infection. Acta Paediatr.\u20081997;86:661\u2013664","DOI":"10.1111\/j.1651-2227.1997.tb08952.x"},{"key":"2021121003230933800_R15","doi-asserted-by":"crossref","unstructured":"Meissner HC, Leung DY. Superantigens, conventional antigens and the etiology of Kawasaki syndrome. Pediatr Infect Dis J.\u20082000;19:91\u201394","DOI":"10.1097\/00006454-200002000-00001"},{"key":"2021121003230933800_R16","doi-asserted-by":"crossref","unstructured":"Yoshioka T, Matsutani T, Toyosaki-Maeda T, et al. Relation of streptococcal pyrogenic exotoxin C as a causative superantigen for Kawasaki disease. Pediatr Res.\u20082003;53:403\u2013410","DOI":"10.1203\/01.PDR.0000049668.54870.50"},{"key":"2021121003230933800_R17","doi-asserted-by":"crossref","unstructured":"Rowley AH. The etiology of Kawasaki disease: superantigen or conventional antigen?Pediatr Infect Dis J.\u20081999;18:69\u201370","DOI":"10.1097\/00006454-199901000-00018"},{"key":"2021121003230933800_R18","doi-asserted-by":"crossref","unstructured":"Esper F, Shapiro ED, Weibel C, Ferguson D, Landry ML, Kahn JS. Association between a novel human coronavirus and Kawasaki disease. J Infect Dis.\u20082005;191:499\u2013502","DOI":"10.1086\/428291"},{"key":"2021121003230933800_R19","doi-asserted-by":"crossref","unstructured":"Rowley AH, Baker SC, Shulman ST, et al. Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody. J Infect Dis.\u20082004;190:856\u2013865","DOI":"10.1086\/422648"},{"key":"2021121003230933800_R20","doi-asserted-by":"crossref","unstructured":"Dajani AS, Taubert KA, Gerber MA, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation.\u20081993;87:1776\u20131780","DOI":"10.1161\/01.CIR.87.5.1776"},{"key":"2021121003230933800_R21","doi-asserted-by":"crossref","unstructured":"de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr.\u20081998;133:254\u2013258","DOI":"10.1016\/S0022-3476(98)70229-X"},{"key":"2021121003230933800_R22","doi-asserted-by":"crossref","unstructured":"Nakano H, Ueda K, Saito A, Nojima K. Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease. Am J Cardiol.\u20081985;56:846\u2013851","DOI":"10.1016\/0002-9149(85)90767-2"},{"key":"2021121003230933800_R23","unstructured":"Diagnostic guidelines for Kawasaki disease. American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease. Am J Dis Child.\u20081990;144:1218\u20131219"},{"key":"2021121003230933800_R24","doi-asserted-by":"crossref","unstructured":"Kuijpers TW, Herweijer TJ, Scholvinck L, Wertheim-Van Dillen PM, Van De Veer EM. Kawasaki disease associated with measles virus infection in a monozygotic twin. Pediatr Infect Dis J.\u20082000;19:350\u2013353","DOI":"10.1097\/00006454-200004000-00018"},{"key":"2021121003230933800_R25","doi-asserted-by":"crossref","unstructured":"Biezeveld MH, Kuipers IM, Geissler J, et al. Association of mannose-binding lectin genotype with cardiovascular abnormalities in Kawasaki disease. Lancet.\u20082003;361:1268\u20131270","DOI":"10.1016\/S0140-6736(03)12985-6"},{"key":"2021121003230933800_R26","doi-asserted-by":"crossref","unstructured":"Rowley AH, Shulman ST, Spike BT, Mask CA, Baker SC. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol.\u20082001;166:1334\u20131343","DOI":"10.4049\/jimmunol.166.2.1334"},{"key":"2021121003230933800_R27","doi-asserted-by":"crossref","unstructured":"Brown TJ, Crawford SE, Cornwall ML, Garcia F, Shulman ST, Rowley AH. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis.\u20082001;184:940\u2013943","DOI":"10.1086\/323155"},{"key":"2021121003230933800_R28","doi-asserted-by":"crossref","unstructured":"Choi IH, Chwae YJ, Shim WS, et al. Clonal expansion of CD8+ T cells in Kawasaki disease. J Immunol.\u20081997;159:481\u2013486","DOI":"10.4049\/jimmunol.159.1.481"},{"key":"2021121003230933800_R29","doi-asserted-by":"crossref","unstructured":"Leung DY, Meissner HC, Shulman ST, et al. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J Pediatr.\u20082002;140:742\u2013746","DOI":"10.1067\/mpd.2002.123664"},{"key":"2021121003230933800_R30","doi-asserted-by":"crossref","unstructured":"Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics.\u20082000;105(6). Available at: www.pediatrics.org\/cgi\/content\/full\/105\/6\/e78","DOI":"10.1542\/peds.105.6.e78"},{"key":"2021121003230933800_R31","doi-asserted-by":"crossref","unstructured":"Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US\/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J.\u20081998;17:1144\u20131148","DOI":"10.1097\/00006454-199812000-00009"},{"key":"2021121003230933800_R32","doi-asserted-by":"crossref","unstructured":"Rosenfeld EA, Corydon KE, Shulman ST. Kawasaki disease in infants less than one year of age. J Pediatr.\u20081995;126:524\u2013529","DOI":"10.1016\/S0022-3476(95)70344-6"},{"key":"2021121003230933800_R33","doi-asserted-by":"crossref","unstructured":"Oki I, Tanihara S, Ojima T, Nakamura Y, Yanagawa H. A multicenter collaborative study on the risk factors of cardiac sequelae due to Kawasaki disease: a one-year follow-up study. Acta Paediatr.\u20082000;89:1435\u20131438","DOI":"10.1111\/j.1651-2227.2000.tb02772.x"},{"key":"2021121003230933800_R34","doi-asserted-by":"crossref","unstructured":"Honkanen VE, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease. Pediatr Cardiol.\u20082003;24:122\u2013126","DOI":"10.1007\/s00246-002-0063-1"},{"key":"2021121003230933800_R35","doi-asserted-by":"crossref","unstructured":"Fukunishi M, Kikkawa M, Hamana K, et al. Prediction of non-responsiveness to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset. J Pediatr.\u20082000;137:172\u2013176","DOI":"10.1067\/mpd.2000.104815"},{"key":"2021121003230933800_R36","doi-asserted-by":"crossref","unstructured":"Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn.\u20081991;33:805\u2013810","DOI":"10.1111\/j.1442-200X.1991.tb02612.x"},{"key":"2021121003230933800_R37","doi-asserted-by":"crossref","unstructured":"Han RK, Silverman ED, Newman A, McCrindle BW. Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease. Arch Pediatr Adolesc Med.\u20082000;154:694\u2013699","DOI":"10.1001\/archpedi.154.7.694"},{"key":"2021121003230933800_R38","unstructured":"Han RK, Sinclair B, Newman A, et al. Recognition and management of Kawasaki disease. CMAJ.\u20082000;162:807\u2013812"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/116\/6\/e760\/1067433\/zpe0120500e760.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/116\/6\/e760\/1067433\/zpe0120500e760.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T14:10:23Z","timestamp":1683295823000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/116\/6\/e760\/63012\/Infections-and-Kawasaki-Disease-Implications-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,1]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2005,12,1]]},"published-print":{"date-parts":[[2005,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2005-0559","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,1]]}}}